Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 22 Jun 2026 – 20 Aug 2026, limited by ICICI Prudential Nifty Smallcap 250 ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential Nifty Smallcap 250 ETF | Nifty Smallcap 250 |
|---|---|---|
| 22 Jun 2026 | ₹100.00 | ₹100.00 |
| 27 Jun 2026 | ₹99.20 | ₹99.19 |
| 02 Jul 2026 | ₹100.76 | ₹100.75 |
| 07 Jul 2026 | ₹100.59 | ₹100.58 |
| 12 Jul 2026 | ₹101.53 | ₹101.51 |
| 17 Jul 2026 | ₹100.93 | ₹100.86 |
| 22 Jul 2026 | ₹100.15 | ₹100.08 |
| 26 Jul 2026 | ₹98.71 | ₹98.61 |
| 31 Jul 2026 | ₹100.53 | ₹100.39 |
| 05 Aug 2026 | ₹102.79 | ₹102.65 |
| 10 Aug 2026 | ₹102.94 | ₹102.78 |
| 15 Aug 2026 | ₹102.59 | ₹102.40 |
| 20 Aug 2026 | ₹102.94 | ₹102.74 |
| Metric | ICICI Prudential NAV ₹18.37 Very High risk Unrated | Category median Other ETFs · 248 funds |
|---|---|---|
| — | +3.65% | |
| — | +10.51% | |
| — | +9.28% | |
| — | +11.93% | |
| +2.94% | +10.38% | |
| +23.58% | — | |
| — | +14.30% | |
| — | +13.74% | |
| — | +12.83% | |
| Risk | ||
| 12.44% | 15.45% | |
| — | 0.28 | |
| — | 0.41 | |
| -3.06% | -20.59% | |
| Nifty Smallcap 250 | — | |
| — | +0.80% | |
| — | 1.00 | |
| — | 102.1% | |
| — | 96.4% | |
| 1.42% | 0.32% | |
| ₹1.13Cr | ₹137.31Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| 22 Jun 2026 | — | |
| 250 | — | |
| 12.1% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.